SCHEMBL9834566

SCHEMBL9834566

CC1Nc2cc3c(cc2N1)NC(=O)C3

nearest known ligand 0.44

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
AHR P35869 4/20 0.44
CMA1 P23946 2/20 0.44
PDE3B Q13370 1/20 0.44
PDE3A Q14432 1/20 0.44
EIF2AK2 P19525 1/20 0.43
EPHX2 P34913 1/20 0.41
PDK2 Q15119 1/20 0.41
BRD4 O60885 4/20 0.41
CREBBP Q92793 3/20 0.41
GRIA1 P42261 2/20 0.41
CACNG8 Q8WXS5 2/20 0.41
PDE4A P27815 1/20 0.38
PDE4B Q07343 1/20 0.38
PDE4C Q08493 1/20 0.38
PDE4D Q08499 1/20 0.38
CRBN Q96SW2 1/20 0.38
PGR P06401 2/20 0.38
PKM P14618 2/20 0.37
KIF11 P52732 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31010750 0.82 AHR (0.59) AHRCMA1PDE3BPDE3AEIF2AK2
SCHEMBL9833717 0.76 PDE3B (0.54) AHRCMA1PDE3BPDE3AEIF2AK2
Hydrochloric Acid SCHEMBL10470469 0.75 PDE3B (0.52) AHRCMA1PDE3BPDE3AEIF2AK2
SCHEMBL9762771 0.75 AHR (0.48) AHRCMA1PDE3BPDE3AEIF2AK2
SCHEMBL10566220 0.73 ALDH1A1 (0.50) AHRCMA1PDE3BPDE3AEIF2AK2
SCHEMBL1436084 0.72 GRIA1 (0.53) AHRCMA1PDE3BPDE3AEIF2AK2
SCHEMBL9298074 0.68 AHR (0.50) AHRCMA1PDE3BPDE3AEIF2AK2
SCHEMBL5441646 0.68 AHR (0.60) AHRCMA1PDE3BPDE3AEIF2AK2
SCHEMBL548762 0.68 AHR (0.50) AHRCMA1PDE3BPDE3AEIF2AK2
SCHEMBL4065845 0.68 AHR (0.60) AHRCMA1PDE3BPDE3AEIF2AK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0214592-B1 PYRROLOBENZIMIDAZOLES, PROCESS FOR THEIR PREPARATION AND MEDICAMENTS CONTAINING THESE PRODUCTS Roche Diagnostics GmbH (DE) 1991-08-14 EP disclosed
US-4730003-A Tricyclic compounds for treating heart and circulatory diseases BOEHRINGER MANNHEIM GMBH (DE) 1988-03-08 US disclosed